Boost the vigorous development of China's biopharmaceuticals exhibition 2020 is ready to launch

COTV GLOBAL LIVE

In recent years, with the growing demand for biomedicine in the market and the increasing attention paid by the state to the research and development of biological innovative drugs, the scale of China's biopharmaceutical industry is growing at a rapid speed and rising to become a national strategic emerging industry. According to the 2016-2020 China pharmaceutical industry investment strategy research and consultation report issued by the China Business Industry Research Institute, in 2020, China's biopharmaceutical market will reach 853.2 billion yuan, with a compound growth rate of 18.1%.

853.2 billion yuan, biopharmaceutical industry has become a hot spot

In the past five years, China's major science and technology programs have invested about 60 billion yuan in the field of life science. In such an environment, China's biotechnology is not only developing rapidly, but also growing in industrial scale. In 2018, the market scale of China's biopharmaceutical industry has exceeded 350 billion yuan, and 9 independently developed class 1 new drugs have been approved for listing, which is a record year for the number of class 1 new drugs approved for listing in China. As of November 2018, the main business income of pharmaceutical industry enterprises above a certain scale in China is nearly 2.6 trillion yuan, an increase of 12.7% year on year, realizing a profit of 336.45 billion yuan. It can be seen that the biopharmaceutical market in the future has a considerable prospect and a huge growth space.

In fact, the research and development of biotechnological drugs in China started late, and it was not until the early s that recombination technology was applied to medicine. However, in recent years, with the promotion of a series of national high-frequency policies and market environment, China's biopharmaceutical industry is facing huge development opportunities. However, opportunities and challenges often coexist. It is important to know that biopharmaceutical industry is an investment field with large investment, slow effect and high risk. How to improve production efficiency, reduce production costs, ensure drug safety and shorten the time to market of new products are all issues that enterprises focus on. So in the face of huge market opportunities and challenges, how should enterprises act in the end?

It is understood that on August 26-28, 2020, the 8th Shanghai International bio fermentation products and Technology Equipment Exhibition (hereinafter referred to as "Shanghai bio fermentation Exhibition") hosted by China Bio Fermentation Industry Association and hosted by Shanghai Xinshi Exhibition Service Co., Ltd. will be held in Shanghai New International Expo Center, where a large number of people of insight will gather to guide the development of bio pharmaceutical industry Dot maze.

2020 Shanghai fermentation exhibition, focusing on all kinds of "new" in biopharmaceutical industry

With the strong support of the policy, the industry said that in the future, it will be a good opportunity for innovation and development of China's biological and pharmaceutical industry. As an integral part of the pharmaceutical, biopharmaceutical, bioengineering, cell engineering, laboratory equipment industry, biological fermentation is bound to usher in a huge development opportunity. In the "tuyere" of the development of biopharmaceutical industry, the 2020 Shanghai bio fermentation exhibition will set off a new round of climax for the innovation and development of biopharmaceutical industry.

It is understood that the 2020 Shanghai fermentation exhibition, as the annual grand event that the global biological fermentation industry is looking forward to, will provide 450 biological fermentation industry exhibitors and 200 biotechnology and biopharmaceutical exhibitors with the same stage of competition with an exhibition area of 40000 square meters, and share more than 40000 professional audiences. At that time, the exhibition will gather new products, new technologies, new processes and new ideas in the biopharmaceutical industry, which can effectively improve the brand, popularity and economic benefits of the industry and help the innovation and development of the biotechnology industry.

In addition, the Shanghai bio fermentation exhibition is also committed to building a professional comprehensive service platform for bio fermentation industry and related industries, which integrates "exhibition, business, learning and exchange" as one of the "industry wide coverage and industry leader"! In addition, various supporting meetings and activities during the exhibition, buyer matching meeting, seminar, exhibition show, exploration tour, selection and award, etc., will create a high-precision international biological fermentation ecosystem.

Conclusion:

At present, China is moving forward from a big country of generic drugs to a powerful country of innovative drugs. In recent years, from the perspective of the development of domestic biomedicine, biopharmaceuticals are gradually becoming the "top students" in the field of innovative drugs with the characteristics of high barriers, low decline and wide application range. Therefore, how to better promote the innovation and development of medicine and biopharmaceutical industry has become the focus of our country's pharmaceutical industry. On August 26-28, 2020, the Shanghai bio fermentation exhibition held in Shanghai New International Expo Center will be the annual feast of the bio fermentation industry. At that time, it will gather the industry leaders. Under the collision of many innovative ideas, it is believed that the majority of pharmaceutical enterprises will get more new development ideas!

reminder:

The investment promotion work of the 8th Shanghai International fermentation exhibition in 2020 is under intense progress, and the booth reservation is currently hot! As a large-scale trade event of